RxDoctor Payments Data

Jeremy Walker, MD

Pain Medicine · Nashville, TNNPI 1699062364

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $19,153 of the $25,076 with a category attached, or 76.4%. Medtronic accounts for 91.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $23,973 and has fallen 99.2% since, to $195 in 2025. Among pain medicine clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,076in general payments, 2019–2025

Across 81 payments — averaging $309.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$23K
  • Boston Scientific$1K
  • Saluda Medical Americas, Inc.$298
  • Abbott$265
  • Stryker$66
  • Biotronik NRO, Inc.$28
  • plus $79 from 5 others

What the payments were for

  • Speaking & faculty fees$19,15376%
  • Travel & lodging$2,74011%
  • Food & beverage$3,15813%
  • Entertainment$250%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,076 in reported general payments places this provider in the 90th percentile of 112 pain medicine providers in Tennessee.

See all pain medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$256,796
Medicare patients
449
Services billed
16,322

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine118$35,449
BelbucaBuprenorphine Hcl12$7,825
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl42$3,919
ZubsolvBuprenorphine Hcl/Naloxone Hcl12$3,614
OxycontinOxycodone Hcl14$3,570
Gabapentin169$3,256
Memantine Hcl129$3,169
Lidocaine24$2,865
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen177$2,541
Pregabalin104$2,384
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen85$1,767
Duloxetine Hcl61$1,434
Naloxone Hcl20$1,240
Mupirocin119$973
Oxycodone Hcl84$957

Paid to pharmacies, not to this prescriber.

Other pain medicine in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →